3D Cell Culture Market Forecasts to 2028 – Global Analysis By Technology (Scaffold-Based, Scaffold-Free), Application (Cancer Research, Drug Discovery), End User (Biopharmaceutical Industry, Hospitals) and By Geography
According to Stratistics MRC, the Global 3D Cell Culture Market is accounted for $1,032.04 million in 2020 and is expected to reach $3,801.10 million by 2028 growing at a CAGR of 17.7% during the forecast period. Increasing focus on developing alternatives to animal testing and increasing incidence of chronic diseases are driving the market growth. However, the high cost of cell biology research is restraining the market growth.
3D Cell Culture is a practice of increasing biological cells and enables biological cells to interact with their surroundings in all three dimensions. This practice allows the cells to develop in their natural environment in an in vivo condition. A variety of techniques is used to carry out culturing of cells in all three dimensions.
Based on the technology, the scaffold-based 3D cell cultures segment is going to have lucrative growth during the forecast period due to the availability of a variety of materials and structural choices and also advantages such as ease of imaging and simple assay protocol.
By geography, Asia Pacific is going to have high growth during the forecast period due to the increase in drug discoveries and the rise in emphasis on the biotechnology industry. Also, the certain number of research and development projects is being initiated in countries. The Government of Japan is focusing more on cell-based regenerative medicine and also the country is making effort in launching new products in the market.
Some of the key players profiled in the 3D Cell Culture include Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza AG, REPROCELL Incorporated, TissUse, InSphero, Synthecon, 3D Biotek, CN Bio, Hamilton Company, MIMETAS, Emulate, Hµrel Corporation, QGel SA, SynVivo, Advanced BioMatrix, Greiner Bio-One International, and PromoCell.
Estimated Market Size in 2020:
USD 1,032.04 million
Compound Annual Growth Rate (CAGR) from 2020 to 2028:
Predicted 2028 Value:
USD 3,801.10 million
Tables, Graphs & Figures
Product, Purpose, Technology, Application, End User and Region
Core Drivers and Opportunities:
Restraining Factors & Market Threats:
• Research Use
• Therapeutic Use
• Scaffold-Based 3D Cell Cultures
• Scaffold-Free 3D Cell Cultures
• Other Technologies
• Biotech Research
• Cancer & Stem Cell Research
• Clinical Applications
• Drug Discovery & Toxicology Testing
• Gene Therapy
• Screening & Development
• Tissue Engineering & Regenerative Medicine
• Tumor Model
End Users Covered:
• Biopharmaceutical Industry
• Contract Research Laboratories & Academic Institutes
• Cosmetics Industry
• Hospitals and Diagnostic Centers
• Pharmaceutical & Biotechnology Companies
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Key Questions Answered In The Report
The Global 3D Cell Culture Market is majorly driven by incidence of chronic diseases, increasing awareness regarding the development of alternate products, and rising investment for the technological upgradation.
The cancer & stem cell research segment is growing at a highest CAGR due to the increasing prevalence of cancer and significant funding for cancer research.
North America dominated with a significant market share due to the increasing incidence of cancer and the presence of a well-established pharmaceutical & biotechnology industry.
Asia Pacific market is growing at a highest CAGR due to increase in drug discoveries and growing demand for stem regenerative & medicine cell therapies.
Key players in 3D Cell Culture Market include 3D Biotek, Advanced BioMatrix, CN Bio, Corning Incorporated, Emulate, Greiner Bio-One International, Hµrel Corporation, Hamilton Company, InSphero, Lonza AG, Merck KGaA, MIMETAS, PromoCell, QGel SA, REPROCELL Incorporated, Synthecon, SynVivo, Thermo Fisher Scientific, and TissUse.
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.